Beta-blockers show no mortality benefit in MI patients with preserved ejection fraction
Beta-blockers do not lower death risk for heart attack patients with strong heart pumps
This meta-analysis of 23,524 adults with myocardial infarction and left ventricular ejection fraction ≥ 40% found that beta-blockers did not…
A large review found beta-blockers did not reduce death or heart failure in adults with heart attacks and normal heart function.
Systematic review of AI/ML methods in myocardial infarction biomarker prediction highlights validation gaps
AI models show strong numbers but lack real-world proof for heart attack patients
This systematic review and proof-of-concept case study examines 120 eligible studies and 152 patients in a proof-of-concept dataset regardin…
A review of 120 studies found AI models often report high accuracy for heart attacks, yet many lack the external testing needed for real cli…
Observational study reveals 'tug-of-war' contraction patterns in healthy and infarcted hearts
New research reveals a hidden heart tug-of-war that causes failure
This observational study describes mesoscale contraction patterns in healthy individuals and patients with myocardial infarction. The author…
A hidden tug-of-war inside your heart explains why some pumps fail while others keep going strong during stress.
AI-Based Adjudication of MACE Events Shows High Agreement with Human CEC in MI Trial
AI Can Spot Heart Attacks and Strokes in Medical Records—But Should We Trust It?
This randomized trial compared an AI-based adjudication system (Auto-MACE) to physician CEC adjudication for MACE events in 5,661 patients w…
This new AI tool could speed up medical research by automatically checking medical records for heart problems, saving doctors hundreds of ho…
Narrative review covers cardiovascular conditions and cognitive decline without reported trial data
Your Heart and Brain Are Talking to Each Other
This narrative review addresses a broad scope of cardiovascular conditions, including stroke, heart failure, atrial fibrillation, and ischem…
Imagine your heart and brain as two best friends who never stop texting each other.
Review Examines IL-32 Role in Cardiovascular Diseases and Atherosclerosis
New Blood Test Could Predict Heart Disease Risk Years Earlier
This review evaluates the role of IL-32 across cardiovascular diseases, atherosclerosis, myocardial infarction, and heart failure. However, …
This research could change how doctors spot heart disease risk, giving patients more time to prevent it.
Review of ginsenoside CK shows potential antiplatelet, anti-inflammatory, and cardioprotective effects in cardiovascular disease models.
This Natural Compound Could Shield Hearts and Prevent Strokes
This review evaluated ginsenoside CK and protopanaxadiol type ginsenosides regarding cardiovascular conditions. The analysis demonstrated an…
A specific compound from ginseng shows strong promise for protecting against heart disease and stroke.
Narrative review summarizes evidence on exercise benefits for cardiovascular disease and mortality risk reduction.
Moving Less Than You Think Saves Your Heart
This narrative review evaluates the relationship between physical activity and cardiovascular outcomes in individuals with and without cardi…
Doing just a little bit of activity every day lowers your risk of dying from heart disease almost as much as powerful medicine.
Review of Visual Standardized Quantification for LGE in Cardiomyopathy
A new tool improves accuracy and speed for spotting heart risks in patients with cardiomyopathy.
This narrative review synthesizes evidence on Visual Standardized Quantification of LGE (VISTAQ) versus conventional techniques. The main fi…
A new imaging method showed better accuracy and faster analysis times for predicting heart events in patients with specific heart diseases.
Meta-analysis of 13 trials finds SGLT2 inhibitors reduce heart failure hospitalization in myocardial infarction.
New Drug Combo Lowers Heart Failure Risk After Heart Attack
This meta-analysis synthesizes data from 13 randomized controlled trials involving 22,238 patients with myocardial infarction. It reports th…
Adding a specific diabetes medication to standard heart care may prevent future heart failure after a heart attack.
Beta-blockers show no benefit in preserved LVEF post-MI, but may help mildly reduced LVEF
Beta-blockers may not lower heart attack risk in patients with normal heart function.
This review of three randomized controlled trials and two meta-analyses found that beta-blocker therapy did not reduce death, MI, or heart f…
A review of trials suggests beta-blockers do not reduce death or heart failure in patients with preserved heart function, but may help those…
Narrative review on ultra-processed foods and cardiovascular disease mechanisms.
How Your Food Choices Rewire Your Heart Signals
This narrative review synthesizes evidence on ultra-processed foods and cardiovascular disease. It distinguishes established, emerging, and …
Ultra-processed foods may send bad signals to your heart cells by changing the tiny messages they use to stay healthy.